atenolol has been researched along with Compensatory Hyperinsulinemia in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Compensatory Hyperinsulinemia: A GLUCOSE-induced HYPERINSULINEMIA, a marker of insulin-resistant state. It is a mechanism to compensate for reduced sensitivity to insulin.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thoma, ME | 1 |
| Glauser, J | 1 |
| Genuth, S | 1 |
1 other study available for atenolol and Compensatory Hyperinsulinemia
| Article | Year |
|---|---|
Persistent hypoglycemia and hyperinsulinemia: caution in using glucagon.
Topics: Adrenergic beta-Antagonists; Alcoholism; Atenolol; Glucagon; Glyburide; Humans; Hyperinsulinism; Hyp | 1996 |